ArticleAntimicrobial agents and chemotherapy2008

Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131.

Tomas Cihlar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.